Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants
Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants
This evaluation is being conducted on the relative new knee system, the Vanguard Cruciate Retaining (CR) to evaluate clinical efficacy of the Vanguard CR components.
This clinical trial was initially designed as a multi-centre, randomized controlled study, comparing the Vanguard CR with the AGC in routine use. The study now is a single centre study.
The Vanguard CR system has been specifically designed to give greater knee stability through the use of more anatomic patello-femoral kinematics.
Inclusion Criteria:
Pre-op knee score of <70
Scheduled to undergo primary total knee replacement with any of the following indication:
Need to obtain pain relief and improve function
Ability and willingness to follow instructions, including control of weight and activity level, and to return for follow-up evaluations
A good nutritional state of the patient
Full skeletal maturity of the patient, patients who are at least 18 years of age.
Patients of either sex
Consent form read, understood, and signed by patient
Exclusion Criteria: